Sunday
4:00 pm - 8:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
7:40 pm - 9:30 pm
Keynote Session: Therapeutic Antibodies
7:40 pm - 7:50 pm
Opening Remarks
7:50 pm - 8:30 pm
"Molecular Dissection of the Human Antibody Response to Respiratory Syncytial Virus"
8:30 pm - 8:40 pm
Discussion
8:40 pm - 9:20 pm
"Using VelociGene to Engineer Mice with Genetically Humanized Immune Systems: From VelocImmune to VelociT"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Antibody Properties and Diversity
This session will focus on understanding how diversity develops during immune response and how this can be used for therapeutic approaches, including the post-translational modifications of antibodies and in particular glycosylation.
9:00 am - 9:25 am
"Understanding Immunity to Influenza by Analyzing the B Cell Repertoire"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
"Humoral and Single Plasma Cell Antibody Responses"
10:00 am - 10:10 am
Discussion
10:10 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Paired Heavy and Light Chain Antibody Sequencing and Functional Analysis of Antiviral Immune Responses"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"From Genome to Glycome: Controlling Natural and Therapeutic Antibody Glycosylation for Targeted Functions"
11:40 am - 11:50 am
Discussion
11:50 am - 12:05 pm
"A Patient Derived Antibody Targeting the Tetraspanin CD9 Inhibits Tumor Progression and Metastasis"
12:05 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"Human Antibodies from Transgenic Chickens"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
3:00 pm - 4:00 pm
Power Hour
The GRC Power Hour is an optional informal gathering open to all meeting participants. It is designed to help address the challenges women face in science and support the professional growth of women in our communities by providing an open forum for discussion and mentoring.
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
New Approaches to Engineering Antibodies
This session focuses on new insights into how antibody structure influences function and considers how antibodies can be manipulated to direct new or preferred functions. This session includes novel antibody like molecules and application of novel methodologies such as CRISPR technology.
6:00 pm - 6:25 pm
"Antibody Engineering Technologies to Solve Unmet Medical Needs"
6:25 pm - 6:35 pm
Discussion
6:35 pm - 7:00 pm
"Patterns of Molecular Convergence in Antibody Repertoires Predict Antigen Exposure and Specificity"
7:00 pm - 7:10 pm
Discussion
7:10 pm - 7:35 pm
"Protein and Glycan Engineering to Expand the Therapeutic Index of Anti-CTLA4"
7:35 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"The Contorsbody: Design, Structure, Function"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Immunoglobulin Effector Function
This session looks at the recent developments in analysis and manipulation of effector functions of human effector leukocytes particularly through classical and non-classical Fc receptors. The session also deals with recently emerging concepts the interplay between effector mechanisms and exogenous factors that influence effector function outcomes in vivo .
9:00 am - 9:25 am
"Precise Humanization of High and Low Affinity hFcγR Represent a Novel Model to Study hFcγR Expression and Function in Mice"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
"Epitope Mapping of IgG and IgE Antigen Specificity for Structure-Function Analyses"
10:00 am - 10:10 am
Discussion
10:10 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"The Good, the Bad, and the TAM: Roles of Tissue Versus Blood Derived Macrophages in Tumor Antibody Activity"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"The Effects of Antibody Glycosylation on Immunoglobulin Effector Function"
11:40 am - 11:45 am
Discussion
11:45 am - 11:55 am
"Binding Geometry of Anti-Human CD32b Antibodies Influences Receptor Localization and Biological Activity"
11:55 am - 12:00 pm
Discussion
12:00 pm - 12:10 pm
"Crossmodulation of Integrins by Monoclonal Antibodies Targeting the Integrin aLβ2"
12:10 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"Single-Chain Antibody Constructs Targeted Towards Activated Platelets as Diagnostic Tools and Therapeutic Agents"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Antibody Cross-Talk
This session examines the in vivo consequences of antibody therapeutics and their impact on immune and other functions including post therapy post therapy "vaccine" effects and how these might be applied in cancer and infectious disease therapies and intervention.
6:00 pm - 6:25 pm
"Stromal Regulation of B and T Cell Immunity"
6:25 pm - 6:35 pm
Discussion
6:35 pm - 7:00 pm
"Antibodies as Templates for Vaccine Against Respiratory Syncytial Virus and HIV-1"
7:00 pm - 7:10 pm
Discussion
7:10 pm - 7:35 pm
"Antibody Engineering by Templated Insertions into Immunoglobulin Genes"
7:35 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"Trim-Away: A New Technology that Uses Antibodies to Rapidly Degrade Cellular Proteins"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Orchestrating Antibody Responses
This session will discuss new approaches to direct antibody development and functionality in vitro and in vivo . New discoveries of the cellular and molecular drivers that shape the repertoire, drive the maturation of antibodies and the manipulation of these processes.
9:00 am - 9:25 am
"The Who, Where, and How B Cells Get Activated"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
"Non-Canonical Roles of Complement in Normal Cell Physiology and in Orchestrating Antibody Responses"
10:00 am - 10:10 am
Discussion
10:10 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Control of Antibody Responses by B Cell Mechanics"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"IgG Fc Domain Repertoires: Structural and Functional Diversity in Humans"
11:40 am - 11:45 am
Discussion
11:45 am - 12:05 pm
"Preclinical Immunogenicity: Interpretation and Clinical Relevance"
12:05 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"Dissecting Antibody Functions in Tuberculosis"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Alternative Antibody Dependent Responses
This session will focus on effector response beyond the traditional FcR-based systems, effector responses. These include unusual immunology aspects of aspects of FcRn, the intracellular receptors of IgG such as TRIM21 that may additionally feed immune responses and the roles of complement and its receptors.
6:00 pm - 6:25 pm
"Activation and Regulation of Cytosolic Antibody Immunity"
6:25 pm - 6:35 pm
Discussion
6:35 pm - 7:00 pm
"The Role of FcRn in Regulating FcγR and the Potential for Exploitation in the Treatment of Autoimmune Diseases"
7:00 pm - 7:10 pm
Discussion
7:10 pm - 7:35 pm
"Molecular Mechanisms of Antibody-Mediated Complement Activation"
7:35 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
"Phase 1 Healthy Volunteer Study of FcRn-Antagonist Efgartigimod Reveals Safe and Sustainable Reduction of IgGs"
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
9:00 am - 12:30 pm
Pre-Clinical Antibody Evaluation
This session will provide new perspectives on the development and evaluation of the activity of antibodies in vivo. This session will also include approaches to understand the immunogenicity of engineered therapeutic monoclonal antibodies.
9:00 am - 9:25 am
"Harnessing Anergy for Development of Non-Depleting B Cell-Targeted Therapies"
9:25 am - 9:35 am
Discussion
9:35 am - 10:00 am
"Translating Antibody Mechanisms of Action into Immunotherapy"
10:00 am - 10:10 am
Discussion
10:10 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Potent Antibody Drug Conjugates for Cancer Therapy"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"Aducanumab, a Member of the Diverse Class of Anti-Abeta Antibodies"
11:40 am - 11:50 am
Discussion
11:50 am - 12:10 pm
"Targeting AXL-Positive Cancers Using a Novel Antibody-Drug Conjugate: Opportunities in Treatment-Resistant Solid Cancers"
12:10 pm - 12:15 pm
Discussion
12:15 pm - 12:25 pm
"Antibody Transport Vehicle: Discovery and Development of Brain Delivery Platform for Biotherapeutics"
12:25 pm - 12:30 pm
Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Keynote Session: Antibodies Therapeutics as Agents of Clinical Change
This session will focus on novel and explorative clinical applications of antibodies and antibody like molecules in cancer and non-cancer indications.
6:00 pm - 6:25 pm
"Next Generation Engineered Antibodies for Cancer Immunotherapy"
6:25 pm - 6:35 pm
Discussion
6:35 pm - 7:00 pm
"IgA as a New Antibody Format to Treat Lymphoma and Neuroblastoma"
7:00 pm - 7:10 pm
Discussion
7:10 pm - 7:50 pm
"When Basic Science Meets Clinical Needs: CD38 and Human Myeloma"
7:50 pm - 7:55 pm
Discussion
7:55 pm - 8:00 pm
Closing Remarks
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure